TD Cowen and Evercore ISI acted as joint book running managers for the offering.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on GRTS:
- Gritstone bio Announces Pricing of $32.5 Million Underwritten Public Offering
- Gritstone bio Announces Proposed Public Offering
- Gritstone bio Announces Positive Preliminary Progression-free Survival and Long-term Circulating Tumor DNA (ctDNA) Data from Phase 2 Portion of Ongoing Phase 2/3 Study of its Personalized Cancer Vaccine, GRANITE, in Front-line Metastatic Microsatellite Stable Colorectal Cancer (MSS-CRC)
- Gritstone reduced workforce by 40% in February
- Gritstone reports FY23 EPS ($1.20) vs ($1.32) last year